𝔖 Bobbio Scriptorium

✦ LIBER ✦

Dose response with darifenacin, a novel once-daily M3selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study

✍ Scribed by Simon Hill; Vik Khullar; Jean-Jacques Wyndaele; Karine Lheritier

Publisher: Springer
Year: 2005
Tongue: English
Weight: 338 KB
Volume: 17
Category: Article
ISSN: 0937-3462
DOI: 10.1007/s00192-005-1340-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of darifenacin

Efficacy and tolerability of darifenacin, a muscarinic M3selective receptor antagonist (M3SRA), compared with oxybutynin in the treatment of patients with overactive bladder

✍ Norman Zinner; John Tuttle; Leonard Marks 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 221 KB

Randomized, placebo-controlled study of

Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study

✍ David J. Moliterno; Robert A. Harrington; Robert M. Califf; Hans J. Rapold; Eric 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 583 KB